Detalhe da pesquisa
1.
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
Hematol Oncol
; 41(3): 555-558, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786526
2.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854643
3.
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cancer
; 126(23): 5069-5076, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910456
4.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Hematol Oncol
; 38(5): 754-762, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950042
5.
Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients.
Hematol Oncol
; 35(4): 828-834, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27255829
6.
Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience.
Cancers (Basel)
; 14(19)2022 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230640
7.
Isavuconazole-Animal Data and Clinical Data.
J Fungi (Basel)
; 6(4)2020 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33036295
8.
Safety of local anesthesia and prevalence of hypersensitivity reactions in adult patients with clonal mast cell diseases: A retrospective single-center study.
J Allergy Clin Immunol Pract
; 9(8): 3224-3226, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857658